PM Narendra Modi held a review meeting on Covid-19 and vaccination (ANI)
NEW DELHI: Amid a record spike in Covid-19 cases, Prime Minister Narendra Modi on Saturday directed officials to make all efforts to utilise the entire national capacity, in public as well as private sector, to ramp up vaccine production.
The PM’s directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and distribution and the government announced stepped up support to Bharat Biotech’s Covaxin and also financial grants to specific facilties in private and public sector to increase vaccine production.
For phase 2, govt buying Covishield cheaper at ₹157.5
SECTIONS
Share
Synopsis
India began its Covid immunisation drive with health and frontline workers on January 16. The current phase, which began on March 1, is aimed at people who are 60 years of age or above and those with comorbidities in the 45-59 age group.
AFP
The government, which hopes to inoculate 270 million persons in the ongoing phase, has placed an order for 100 million doses with SII at this price.
The government has renegotiated the price at which it procures Covishield, made by Serum Institute of India (SII), to about ₹160 per dose for the current phase of the vaccination programme, from ₹210 previously, inclusive of taxes.
Covaxin efficacy of 81% testament to India s rise as global vaccine superpower: ICMR DG
The interim efficacy trend of 81 per cent, analysed as per the protocol approved by the Drugs Controller General of India, puts it at par with other global front-runner vaccines, stated ICMR
Joe C Mathew | March 3, 2021 | Updated 19:42 IST
Indian Council of Medical Research (ICMR) has said that the interim efficacy results of Bharat Biotech s COVID-19 vaccine, Covaxin, showcases the immense strength of Atmanirbhar Bharat to fight the odds and stand tall in the global public health community.
The vaccine is the result of a partnership between ICMR and Bharat Biotech International Limited (BBIL).
Covaxin (Photo Credits: Bharat Biotech)
Hyderabad, February 24: Ukraine s Health Minister Maksym Stepanov on Wednesday visited Bharat Biotech s manufacturing facility here and held discussions on supplies of the company s Covid-19 vaccine Covaxin for his country.
A three-member led by the minister took a tour of the world-class Bio-Safety Level 3 manufacturing facility of Bharat Biotech, which has developed India s first indigenous vaccine for Covid-19.
The delegation, that included Deputy Health Minister Igor Ivashchenko, and Ukraine Embassy s Head of Trade and Economic Department Ivan Konovalov had discussions with Bharat Biotech s leadership to secure the supplies of Covaxin to Ukraine.
Bharat Biotech International Limited Chairman & Managing Director Dr Krishna Ella said it was privilege to host the Health Minister from Ukraine at our state-of-the-art facility and showcase our world-class capabilities in the manufacture and supply of vaccines and research and product de